Glutathione peroxidase 1 activity dictates the sensitivity of glioblastoma cells to oxidative stress

GLIA

Volumn 60, Issue 11, 2012, Pages 1785-1800

  Dokic, Ivana ^a   Hartmann, Christian ^b   Herold Mende, Christel ^c   Régnier Vigouroux, Anne ^a,d  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Antioxidant enzymes; Cell death; Glial cells; Glioma; Reactive oxygen species

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 1; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ARTICLE; CELL DEATH; ENZYME ACTIVITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; MACROPHAGE; MICROGLIA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BRAIN NEOPLASMS; CATALASE; CELL LINE, TUMOR; GLIOBLASTOMA; GLUTATHIONE PEROXIDASE; HUMANS; MICE; NEUROGLIA; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 84865863533     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22397     Document Type: Article

References (59)

1. Abreu IA, Cabelli DE. 2010. Superoxide dismutases-A review of the metal-associated mechanistic variations. Biochim Biophys Acta 1804: 263-274.
2. Antunes F, Han D, Cadenas E. 2002. Relative contributions of heart mitochondria glutathione peroxidase and catalase to H(2)O(2) detoxification in in vivo conditions. Free Radic Biol Med 33: 1260-1267.
3. Baud O, Greene AE, Li J, Wang H, Volpe JJ, Rosenberg PA. 2004. Glutathione peroxidase-catalase cooperativity is required for resistance to hydrogen peroxide by mature rat oligodendrocytes. J Neurosci 24: 1531-1540.
4. Bonavia R, Inda MM, Cavenee WK, Furnari FB. 2011. Heterogeneity maintenance in glioblastoma: A social network. Cancer Res 71: 4055-4060.
5. Brigelius-Flohe R. 1999. Tissue-specific functions of individual glutathione peroxidases. Free Radic Biol Med 27: 951-965.
6. Brigelius-Flohe R, Kipp A. 2009. Glutathione peroxidases in different stages of carcinogenesis. Biochim Biophys Acta 1790: 1555-1568.
7. Burudi EM, Riese S, Stahl PD, Regnier-Vigouroux A. 1999. Identification and functional characterization of the mannose receptor in astrocytes. Glia 25: 44-55.
8. Campos B, Wan F, Farhadi M, Ernst A, Zeppernick F, Tagscherer KE, Ahmadi R, Lohr J, Dictus C, Gdynia G, Combs SE, Goidts V, Helmke BM, Eckstein V, Roth W, Beckhove P, Lichter P, Unterberg A, Radlwimmer B, Herold-Mende C. 2010. Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin Cancer Res 16: 2715-2728.
9. Chaudiere J, Wilhelmsen EC, Tappel AL. 1984. Mechanism of selenium-glutathione peroxidase and its inhibition by mercaptocarboxylic acids and other mercaptans. J Biol Chem 259: 1043-1050.
10. Di Piazza M, Mader C, Geletneky K, Herrero YCM, Weber E, Schlehofer J, Deleu L, Rommelaere J. 2007. Cytosolic activation of cathepsins mediates parvovirus H-1-induced killing of cisplatin and TRAIL-resistant glioma cells. J Virol 81: 4186-4198.
11. Doroshow JH. 1995. Glutathione peroxidase and oxidative stress. Toxicol Lett 82-83: 395-398.
12. Dringen R. 2005. Oxidative and antioxidative potential of brain microglial cells. Antioxid Redox Signal 7: 1223-1233.
13. Dringen R, Gutterer JM, Hirrlinger J. 2000. Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur J Biochem 267: 4912-4916.
14. Driscoll DM, Copeland PR. 2003. Mechanism and regulation of selenoprotein synthesis. Annu Rev Nutr 23: 17-40.
15. El Sayed SM, Abou El-Magd RM, Shishido Y, Chung SP, Sakai T, Watanabe H, Kagami S, Fukui K. 2012. D-Amino acid oxidase gene therapy sensitizes glioma cells to the antiglycolytic effect of 3-bromopyruvate. Cancer Gene Ther 19: 1-18.
16. Haapasalo H, Kylaniemi M, Paunul N, Kinnula VL, Soini Y. 2003. Expression of antioxidant enzymes in astrocytic brain tumors. Brain Pathol 13: 155-164.
17. Halliwell B. 1992. Reactive oxygen species and the central nervous system. J Neurochem 59: 1609-1623.
18. Halliwell B. 2007. Oxidative stress and cancer: Have we moved forward? Biochem J 401: 1-11.
19. Halliwell B, Gutteridge JMC. 1985. Free radicals in biology and medicine. Oxford, New York: Clarendon Press, Oxford University Press.
20. Harris CA, Derbin KS, Hunte-McDonough B, Krauss MR, Chen KT, Smith DM, Epstein LB. 1991. Manganese superoxide dismutase is induced by IFN-γ in multiple cell types. Synergistic induction by IFN-γ and tumor necrosis factor or IL-1. J Immunol 147: 149-154.
21. Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A, Felsberg J, Wolter M, Mawrin C, Wick W, Weller M, Herold-Mende C, Unterberg A, Jeuken JW, Wesseling P, Reifenberger G, von Deimling A. 2009. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: A study of 1, 010 diffuse gliomas. Acta Neuropathol 118: 469-474.
22. Hempel SL, Buettner GR, O'Malley YQ, Wessels DA, Flaherty DM. 1999. Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: Comparison with 2', 7'-dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2', 7'-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123. Free Radic Biol Med 27: 146-159.
23. Hirrlinger J, Dringen R. 2010. The cytosolic redox state of astrocytes: Maintenance, regulation and functional implications for metabolite trafficking. Brain Res Rev 63: 177-188.
24. Hu Y, Benya RV, Carroll RE, Diamond AM. 2005. Allelic loss of the gene for the GPX1 selenium-containing protein is a common event in cancer. J Nutr 135 ( 12 Suppl): 3021S-3024S.
25. Kallin A, Johannessen LE, Cani PD, Marbehant CY, Essaghir A, Foufelle F, Ferre P, Heldin CH, Delzenne NM, Demoulin JB. 2007. SREBP-1 regulates the expression of heme oxygenase 1 and the phosphatidylinositol-3 kinase regulatory subunit p55 γ. J Lipid Res 48: 1628-1636.
26. Karcher S, Steiner HH, Ahmadi R, Zoubaa S, Vasvari G, Bauer H, Unterberg A, Herold-Mende C. 2006. Different angiogenic phenotypes in primary and secondary glioblastomas. Int J Cancer 118: 2182-2189.
27. Kees T, Lohr J, Noack J, Mora R, Gdynia G, Todt G, Ernst A, Radlwimmer B, Falk CS, Herold-Mende C, Regnier-Vigouroux A. 2012. Microglia isolated from patients with glioma gain antitumor activities on poly (I:C) stimulation. Neuro Oncol 14: 64-78.
28. Koh YH, von Arnim CA, Hyman BT, Tanzi RE, Tesco G. 2005. BACE is degraded via the lysosomal pathway. J Biol Chem 280: 32499-32504.
29. Kussmaul L, Hamprecht B, Dringen R. 1999. The detoxification of cumene hydroperoxide by the glutathione system of cultured astroglial cells hinges on hexose availability for the regeneration of NADPH. J Neurochem 73: 1246-1253.
30. Lee DH, Goldberg AL. 1998. Proteasome inhibitors: Valuable new tools for cell biologists. Trends Cell Biol 8: 397-403.
31. Lee HC, Kim DW, Jung KY, Park IC, Park MJ, Kim MS, Woo SH, Rhee CH, Yoo H, Lee SH, Hong SI. 2004. Increased expression of antioxidant enzymes in radioresistant variant from U251 human glioblastoma cell line. Int J Mol Med 13: 883-887.
32. Li S, Yan T, Yang JQ, Oberley TD, Oberley LW. 2000. The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res 60: 3927-3939.
33. Liddell JR, Dringen R, Crack PJ, Robinson SR. 2006. Glutathione peroxidase 1 and a high cellular glutathione concentration are essential for effective organic hydroperoxide detoxification in astrocytes. Glia 54: 873-879.
34. Lubos E, Loscalzo J, Handy DE. 2011. Glutathione peroxidase-1 in health and disease: From molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 15: 1957-1997.
35. Matsumoto K, Akao Y, Yi H, Shamoto-Nagai M, Maruyama W, Naoi M. 2006. Overexpression of amyloid precursor protein induces susceptibility to oxidative stress in human neuroblastoma SH-SY5Y cells. J Neural Transm 113: 125-135.
36. Mora R, Dokic I, Kees T, Huber CM, Keitel D, Geibig R, Brugge B, Zentgraf H, Brady NR, Regnier-Vigouroux A. 2010. Sphingolipid rheostat alterations related to transformation can be exploited for specific induction of lysosomal cell death in murine and human glioma. Glia 58: 1364-1383.
37. Nakano T, Oka K, Taniguchi N. 1996. Manganese superoxide dismutase expression correlates with p53 status and local recurrence of cervical carcinoma treated with radiation therapy. Cancer Res 56: 2771-2775.
38. Oberley LW, Buettner GR. 1979. Role of superoxide dismutase in cancer: A review. Cancer Res 39: 1141-1149.
39. Oliva J, French SW, Li J, Bardag-Gorce F. 2012. Proteasome inhibitor treatment reduced fatty acid, triacylglycerol and cholesterol synthesis. Exp Mol Pathol 93: 26-34.
40. Ross GM. 1999. Induction of cell death by radiotherapy. Endocr Relat Cancer 6: 41-44.
41. Shanker G, Aschner JL, Syversen T, Aschner M. 2004. Free radical formation in cerebral cortical astrocytes in culture induced by methylmercury. Brain Res Mol Brain Res 128: 48-57.
42. Sharma V, Joseph C, Ghosh S, Agarwal A, Mishra MK, Sen E. 2007. Kaempferol induces apoptosis in glioblastoma cells through oxidative stress. Mol Cancer Ther 6: 2544-2553.
43. Sies H. 1991. Role of reactive oxygen species in biological processes. Klin Wochenschr 69: 965-968.
44. Sies H, Sharov VS, Klotz LO, Briviba K. 1997. Glutathione peroxidase protects against peroxynitrite-mediated oxidations. A new function for selenoproteins as peroxynitrite reductase. J Biol Chem 272: 27812-27817.
45. Simmons TW, Jamall IS. 1989. Relative importance of intracellular glutathione peroxidase and catalase in vivo for prevention of peroxidation to the heart. Cardiovasc Res 23: 774-779.
46. Singh SK, Clarke ID, Hide T, Dirks PB. 2004. Cancer stem cells in nervous system tumors. Oncogene 23: 7267-7273.
47. Smith PS, Zhao W, Spitz DR, Robbins ME. 2007. Inhibiting catalase activity sensitizes 36B10 rat glioma cells to oxidative stress. Free Radic Biol Med 42: 787-797.
48. Szabo C, Ischiropoulos H, Radi R. 2007. Peroxynitrite: Biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 6: 662-680.
49. Tanaka RD, Li AC, Fogelman AM, Edwards PA. 1986. Inhibition of lysosomal protein degradation inhibits the basal degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Lipid Res 27: 261-273.
50. Tanriverdi T, Hanimoglu H, Kacira T, Sanus GZ, Kemerdere R, Atukeren P, Gumustas K, Canbaz B, Kaynar MY. 2007. Glutathione peroxidase, glutathione reductase and protein oxidation in patients with glioblastoma multiforme and transitional meningioma. J Cancer Res Clin Oncol 133: 627-633.
51. Tsan MF, Clark RN, Goyert SM, White JE. 2001. Induction of TNF-α and MnSOD by endotoxin: Role of membrane CD14 and toll-like receptor-4. Am J Physiol Cell Physiol 280: C1422-C1430.
52. Tuominen VJ, Ruotoistenmaki S, Viitanen A, Jumppanen M, Isola J. 2010. ImmunoRatio: A publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Breast Cancer Res 12: R56.
53. Vlashi E, Lagadec C, Vergnes L, Matsutani T, Masui K, Poulou M, Popescu R, Della Donna L, Evers P, Dekmezian C, Reue K, Christofk H, Mischel PS, Pajonk F. 2011. Metabolic state of glioma stem cells and nontumorigenic cells. Proc Natl Acad Sci USA 108: 16062-16067.
54. Wilson JX. 1997. Antioxidant defense of the brain: A role for astrocytes. Can J Physiol Pharmacol 75: 1149-1163.
55. Winter S, Strik H, Rieger J, Beck J, Meyermann R, Weller M. 2000. Glutathione S-transferase and drug sensitivity in malignant glioma. J Neurol Sci 179: 115-121.
56. Wong GH, Goeddel DV. 1988. Induction of manganous superoxide dismutase by tumor necrosis factor: Possible protective mechanism. Science 242: 941-944.
57. Woolston CM, Al-Attar A, Storr SJ, Ellis IO, Morgan DA, Martin SG. 2011a. Redox protein expression predicts radiotherapeutic response in early-stage invasive breast cancer patients. Int J Radiat Oncol Biol Phys 79: 1532-1540.
58. Woolston CM, Storr SJ, Ellis IO, Morgan DA, Martin SG. 2011b. Expression of thioredoxin system and related peroxiredoxin proteins is associated with clinical outcome in radiotherapy treated early stage breast cancer. Radiother Oncol 100: 308-313.
59. Zhong W, Yan T, Lim R, Oberley LW. 1999. Expression of superoxide dismutases, catalase, and glutathione peroxidase in glioma cells. Free Radic Biol Med 27: 1334-1345.